These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31377734)

  • 1. Heparin and citrate additive carryover during blood collection.
    Keppel MH; Auer S; Lippi G; von Meyer A; Cornes M; Felder TK; Oberkofler H; Mrazek C; Haschke-Becher E; Cadamuro J
    Clin Chem Lab Med; 2019 Nov; 57(12):1888-1896. PubMed ID: 31377734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
    Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
    Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of experimental hypercalcemia on routine haemostasis testing.
    Lippi G; Salvagno GL; Brocco G; Gelati M; Danese E; Favaloro EJ
    PLoS One; 2017; 12(3):e0175094. PubMed ID: 28362859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration.
    Adcock DM; Kressin DC; Marlar RA
    Am J Clin Pathol; 1998 May; 109(5):595-9. PubMed ID: 9576579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ; Dimond EP; Kramer W; Horne MK
    Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).
    Kristoffersen AH; Stavelin AV; Ajzner E; Kristensen GBB; Sandberg S; Van Blerk M; Kitchen S; Kesseler D; Woods TAL; Meijer P
    Clin Chem Lab Med; 2019 Sep; 57(10):1511-1521. PubMed ID: 31085743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium citrate blood contamination by K2 -ethylenediaminetetraacetic acid (EDTA): impact on routine coagulation testing.
    Lima-Oliveira G; Salvagno GL; Danese E; Favaloro EJ; Guidi GC; Lippi G
    Int J Lab Hematol; 2015 Jun; 37(3):403-9. PubMed ID: 25308126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of EDTA carryover during blood collection.
    Cadamuro J; Felder TK; Oberkofler H; Mrazek C; Wiedemann H; Haschke-Becher E
    Clin Chem Lab Med; 2015 Jul; 53(8):1271-8. PubMed ID: 25720083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine coagulation testing in Vacutainer® Citrate Plus tubes filled at minimum or optimal volume.
    Balboni F; Barbui S; Gallo M; Berardi M; Vezzosi M; Lippi G
    Diagnosis (Berl); 2020 Jan; 7(1):55-60. PubMed ID: 31421038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®.
    Ver Elst K; Vermeiren S; Schouwers S; Callebaut V; Thomson W; Weekx S
    Int J Lab Hematol; 2013 Dec; 35(6):614-9. PubMed ID: 23663653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contamination of coagulation tests with heparin from blood gas samples.
    Brown JM; Dimeski G
    Br J Anaesth; 2001 Oct; 87(4):628-9. PubMed ID: 11878734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low volume specimen container suitable for monitoring the aPTT of heparinized patients.
    Ray MJ; Carroll PA; Just SJ; Hawson GA
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):805-7. PubMed ID: 8292732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.
    Adcock DM; Kressin DC; Marlar RA
    Am J Clin Pathol; 1997 Jan; 107(1):105-10. PubMed ID: 8980376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of coagulation test results from heparinized central venous catheter and venipuncture.
    Jeon M; Han A; Kang H; Lee KH; Lee JH; Lee JH
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):145-151. PubMed ID: 31977327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The order of draw: much ado about nothing?
    Indevuyst C; Schuermans W; Bailleul E; Meeus P
    Int J Lab Hematol; 2015 Feb; 37(1):50-5. PubMed ID: 24712307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy screening in children with heparinized central venous catheters.
    Ellis MR
    Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative estimation of preanalytical variables which may influence the determinations of prothrombin time (PT) and activated partial thromboplastin time (APTT)].
    Isa K; Yamauchi MS; Nago TT; Yamane N
    Rinsho Byori; 2010 Oct; 58(10):979-85. PubMed ID: 21077287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Samples in Coagulation Test].
    Komiyama Y
    Rinsho Byori; 2015 Dec; 63(12):1397-404. PubMed ID: 27089656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collection of blood specimens by venipuncture for plasma-based coagulation assays: necessity of a discard tube.
    Raijmakers MT; Menting CH; Vader HL; van der Graaf F
    Am J Clin Pathol; 2010 Feb; 133(2):331-5. PubMed ID: 20093244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.